Procter & Gamble Health (BOM:500126) Scaled Net Operating Assets: N/A (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:500126 Procter & Gamble Health Ltd BOM:500126
86 GF Score
Price ₹6,723.60
GF Value ₹6,080.91
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Procter & Gamble Health Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Procter & Gamble Health's operating assets for the quarter that ended in Mar. 2026 was ₹6,399 Mil. Procter & Gamble Health's operating liabilities for the quarter that ended in Mar. 2026 was ₹3,075 Mil. Procter & Gamble Health's Total Assets for the quarter that ended in Dec. 2025 was ₹0 Mil. Therefore, Procter & Gamble Health's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was N/A.

Procter & Gamble Health Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Procter & Gamble Health's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Procter & Gamble Health Scaled Net Operating Assets Chart

Procter & Gamble Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Jun21 Jun22 Jun23 Jun24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.23 0.30 0.37 0.28

Procter & Gamble Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BOM:500126 vs ZTS: Scaled Net Operating Assets Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Procter & Gamble Health's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Procter & Gamble Health Scaled Net Operating Assets vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Procter & Gamble Health's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Procter & Gamble Health's Scaled Net Operating Assets falls into.


BOM:500126
86GF Score
Procter & Gamble Health Ltd BOM:500126
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Procter & Gamble Health Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Procter & Gamble Health's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jun. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Jun. 2024 )
=(Operating Assets (A: Jun. 2024 )-Operating Liabilities (A: Jun. 2024 ))/Total Assets (A: Jun. 2023 )
=(5558.6-2465.6)/11011.9
=0.28

where

Operating Assets(A: Jun. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=7943.6 - 2385
=5558.6

Operating Liabilities(A: Jun. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=2561.2 - 68.8 - 26.8
=2465.6

Procter & Gamble Health's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2026 )
=(Operating Assets (Q: Mar. 2026 )-Operating Liabilities (Q: Mar. 2026 ))/Total Assets (Q: Dec. 2025 )
=(6398.9-3075.1)/0
=N/A

where

Operating Assets(Q: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=8413.5 - 2014.6
=6398.9

Operating Liabilities(Q: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=3168 - 57.2 - 35.7
=3075.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Procter & Gamble Health (BOM:500126) Overvalued in 2026?

Based on GuruFocus' analysis, Procter & Gamble Health stock appears to be overvalued. The current stock price of ₹6,723.60 is trading 10.6% above its estimated GF Value™ of ₹6,080.91. GuruFocus considers Procter & Gamble Health to be Modestly Overvalued.

Key valuation signals for BOM:500126:

  • Scaled Net Operating Assets: N/A
  • GF Value™: ₹6,080.91 vs. price of ₹6,723.60 (10.6% above fair value)
  • GF Score™: 86/100 with 6 warning signs

No single metric tells the full story. See the BOM:500126 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Procter & Gamble Health Business Description

Other Exchanges PGHL:India
Address Cardinal Gracias Road, Ground Floor And First Floor, P&G Plaza, Chakala, Andheri East, Mumbai, MH, IND, 400099
Procter & Gamble Health Ltd is an India based pharmaceutical company engaged in manufacturing and selling of healthcare products, viz., vitamins, minerals and supplements. Patients are end consumers of the products. The Company's distribution channels (direct & indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. Cosome, Evion, Neurobion, Nasivion, Polybion, Livogen and Seven Seas are some of the brands of the company. The geographical segments include sales in India and exports.
86GF Score

Get the complete analysis for BOM:500126

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹6,723.60
Price
₹6,080.91
GF Value